Seulhee Kim

435 total citations
18 papers, 294 citations indexed

About

Seulhee Kim is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Seulhee Kim has authored 18 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Immunology. Recurrent topics in Seulhee Kim's work include Extracellular vesicles in disease (4 papers), Mitochondrial Function and Pathology (4 papers) and RNA Interference and Gene Delivery (4 papers). Seulhee Kim is often cited by papers focused on Extracellular vesicles in disease (4 papers), Mitochondrial Function and Pathology (4 papers) and RNA Interference and Gene Delivery (4 papers). Seulhee Kim collaborates with scholars based in United States. Seulhee Kim's co-authors include Lufang Zhou, Margaret Liu, Yingnan Si, Renata Jaskula‐Sztul, Herbert Chen, Yawen Tang, James M. Markert, Eric Erquan Zhang, Patrick Erñst and Yuanxin Xu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and American Journal of Physiology-Heart and Circulatory Physiology.

In The Last Decade

Seulhee Kim

18 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Seulhee Kim United States	10	183	95	51	51	40	18	294
Yingnan Si United States	12	189 1.0×	128 1.3×	49 1.0×	75 1.5×	42 1.1×	18	334
Elizabeth A. Loughran United States	7	202 1.1×	132 1.4×	90 1.8×	35 0.7×	19 0.5×	9	393
Romain Salza France	7	200 1.1×	57 0.6×	91 1.8×	20 0.4×	26 0.7×	8	365
Paige Baldwin United States	9	177 1.0×	244 2.6×	27 0.5×	37 0.7×	19 0.5×	24	389
Zeyao Zhu China	12	181 1.0×	81 0.9×	83 1.6×	15 0.3×	26 0.7×	28	330
Mayuri Prasad United States	10	236 1.3×	52 0.5×	69 1.4×	41 0.8×	23 0.6×	15	351
Μαργαρίτα Λάμπρου Greece	11	164 0.9×	32 0.3×	64 1.3×	56 1.1×	12 0.3×	19	323
Filomena Spada Italy	8	292 1.6×	38 0.4×	24 0.5×	78 1.5×	29 0.7×	11	415
Biao Duan China	11	185 1.0×	56 0.6×	48 0.9×	52 1.0×	11 0.3×	19	317
Víctor Navarro-Tableros Italy	14	241 1.3×	26 0.3×	104 2.0×	52 1.0×	59 1.5×	22	540

Countries citing papers authored by Seulhee Kim

Since Specialization

Citations

This map shows the geographic impact of Seulhee Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seulhee Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seulhee Kim more than expected).

Fields of papers citing papers by Seulhee Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seulhee Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seulhee Kim. The network helps show where Seulhee Kim may publish in the future.

Co-authorship network of co-authors of Seulhee Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Seulhee Kim. A scholar is included among the top collaborators of Seulhee Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seulhee Kim. Seulhee Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Kim, Seulhee, Patrick Erñst, Li Zhu, et al.. (2025). Optogenetic mitochondrial preconditioning enhances cardiomyocyte survival under stress. Journal of Molecular and Cellular Cardiology. 205. 24–36. 1 indexed citations

Kim, Seulhee, et al.. (2024). Advanced biomanufacturing and evaluation of adeno-associated virus. Journal of Biological Engineering. 18(1). 15–15. 6 indexed citations

Ernst, P, Seulhee Kim, Yingnan Si, et al.. (2024). mLumiOpto Is a Mitochondrial-Targeted Gene Therapy for Treating Cancer. Cancer Research. 84(23). 4049–4065. 7 indexed citations

Si, Yingnan, et al.. (2024). A Dual-Payload Antibody–Drug Conjugate Targeting CD276/B7-H3 Elicits Cytotoxicity and Immune Activation in Triple-Negative Breast Cancer. Cancer Research. 84(22). 3848–3863. 16 indexed citations

Chen, Kai, et al.. (2023). A CD276-Targeted Antibody-Drug Conjugate to Treat Non-Small Lung Cancer (NSCLC). Cells. 12(19). 2393–2393. 2 indexed citations

Erñst, Patrick, et al.. (2023). Characterization of the far-red fluorescent probe MitoView 633 for dynamic mitochondrial membrane potential measurement. Frontiers in Physiology. 14. 1257739–1257739. 6 indexed citations

Si, Yingnan, et al.. (2022). Process Improvement of Adeno-Associated Virus Production. SHILAP Revista de lepidopterología. 4. 24 indexed citations

Si, Yingnan, et al.. (2022). Abstract 5958: CD276/CD47-targeted antibody-drug conjugates to treat triple-negative breast cancers. Cancer Research. 82(12_Supplement). 5958–5958. 1 indexed citations

Si, Yingnan, Kai Chen, Seulhee Kim, et al.. (2022). Targeted EV to Deliver Chemotherapy to Treat Triple-Negative Breast Cancers. Pharmaceutics. 14(1). 146–146. 15 indexed citations

10.

Si, Yingnan, Seulhee Kim, Tae Hyun Kim, et al.. (2022). Targeted Extracellular Vesicles Delivered Verrucarin A to Treat Glioblastoma. Biomedicines. 10(1). 130–130. 16 indexed citations

11.

Erñst, Patrick, Kai Chen, Yawen Tang, et al.. (2021). Investigation into the difference in mitochondrial-cytosolic calcium coupling between adult cardiomyocyte and hiPSC-CM using a novel multifunctional genetic probe. Pflügers Archiv - European Journal of Physiology. 473(3). 447–459. 6 indexed citations

12.

Si, Yingnan, Seulhee Kim, Patrick Erñst, et al.. (2021). Antibody–Drug Conjugate to Treat Meningiomas. Pharmaceuticals. 14(5). 427–427. 7 indexed citations

13.

Si, Yingnan, Seulhee Kim, Yun Lü, et al.. (2020). Anti-SSTR2 antibody-drug conjugate for neuroendocrine tumor therapy. Cancer Gene Therapy. 28(7-8). 799–812. 29 indexed citations

14.

Kim, Seulhee, Jiajia Song, Patrick Erñst, et al.. (2020). MitoQ regulates redox-related noncoding RNAs to preserve mitochondrial network integrity in pressure-overload heart failure. American Journal of Physiology-Heart and Circulatory Physiology. 318(3). H682–H695. 38 indexed citations

15.

Si, Yingnan, Yuanxin Xu, Kai Chen, et al.. (2020). Anti‐EGFR antibody‐drug conjugate for triple‐negative breast cancer therapy. Engineering in Life Sciences. 21(1-2). 37–44. 28 indexed citations

16.

Si, Yingnan, Yuanxin Xu, Kai Chen, et al.. (2020). Dual-Targeted Extracellular Vesicles to Facilitate Combined Therapies for Neuroendocrine Cancer Treatment. Pharmaceutics. 12(11). 1079–1079. 18 indexed citations

17.

Si, Yingnan, Yawen Tang, Yun Lü, et al.. (2019). Novel biomanufacturing platform for large-scale and high-quality human T cells production. Journal of Biological Engineering. 13(1). 34–34. 13 indexed citations

18.

Si, Yingnan, Seulhee Kim, Eric Erquan Zhang, et al.. (2019). Targeted Exosomes for Drug Delivery: Biomanufacturing, Surface Tagging, and Validation. Biotechnology Journal. 15(1). e1900163–e1900163. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact